Actively Recruiting
Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
Led by Xuanwu Hospital, Beijing · Updated on 2025-07-28
128
Participants Needed
1
Research Sites
126 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study aims to explore the imaging and electrophysiological characteristics of idiopathic inflammatory demyelinating diseases (IIDDs), and their correlation with clinical manifestations. It also evaluates the effectiveness of transcranial electrical stimulation in alleviating clinical symptoms of IIDDs patients, and analyzes the key factors affecting the treatment efficacy. By uncovering the overall and individual characteristics of IIDDs, this study seeks to enhance therapeutic outcomes through personalized neuromodulation programs. The findings will provide a basis for applying non-invasive brain stimulation (NIBS) in IIDDs treatment and offer new ideas for future personalized medicine approaches.
CONDITIONS
Official Title
Assessment of Transcranial Alternating Current Stimulation's Clinical Efficacy in Treating Cognitive Impairment of Idiopathic Inflammatory Demyelinating Diseases
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 60 years old
- Diagnosed with neuromyelitis optica spectrum disease, multiple sclerosis, or other inflammatory demyelinating diseases of the central nervous system meeting diagnostic criteria
- Medications have been stable for at least three months
You will not qualify if you...
- Disease recurrence recorded in the past 3 months
- Presence of pacemaker or metal implant in the body
- Impaired skin integrity where electrodes would be placed
- Prior organic brain diseases such as epilepsy, hydrocephalus, central nervous system tumors, brain injury, or intracranial infection
- Severe or unstable organic diseases including heart, liver, kidney, or other organ dysfunction
- Pregnancy, lactation, or planning pregnancy in the near future
- Poor compliance with study requirements
- Any other condition deemed unsuitable by the investigator for study participation
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100053
Actively Recruiting
Research Team
H
huang huijin, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here